Senses Disorder TRIZ Cases
- Neramexane Formulation for NMDA-Mediated Hearing Loss
NMDA receptor blockade with neramexane helps relieve hearing loss and tinnitus while improving efficacy through dosage and release formulation choices.
- Substituted Cyclopentane Compounds for Ocular Pressure Reduction
Cyclopentane-based ocular hypotensive compounds lower intraocular pressure by promoting aqueous humor drainage while addressing limits of beta blockers.
- Neramexane Titration Package for Tinnitus Dose Escalation
Gradual neramexane dose escalation reaches an effective tinnitus treatment level while limiting adverse events through a structured multi-dose package.
- Neramexane Dual-Receptor Therapy for Cochlear Tinnitus
Targeting both NMDA and α9/α10 nicotinic receptors, neramexane reduces cochlear tinnitus and annoyance linked to hearing loss.
- Neramexane Titration Package for Faster Dosing With Fewer Side Effects
Gradual neramexane dose escalation with multi-dose packaging reaches effective tinnitus treatment levels while limiting side effects.